# Local LevoBupivacaine for Pain Relief After Endoscopic Submucosal Dissection for Esophageal Lesions

> **NCT06611176** · NA · RECRUITING · sponsor: **Laura Boer** · enrollment: 88 (estimated)

## Conditions studied

- Endoscopic Submucosal Dissection
- Levobupivacaine

## Interventions

- **DRUG:** Local levobupivacaine

## Key facts

- **NCT ID:** NCT06611176
- **Lead sponsor:** Laura Boer
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-30
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06611176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06611176, "Local LevoBupivacaine for Pain Relief After Endoscopic Submucosal Dissection for Esophageal Lesions". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06611176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*